FDA Inspection 1131467 — David J. Smith Jr, MD

David J. Smith Jr, MD — FEI 3017213758

The FDA completed an inspection of David J. Smith Jr, MD on October 13, 2020 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2020
Fiscal Year
2021
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Tampa, FL (United States)

Additional Details

Clinical Investigator (CI)